chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site erythema, Injection site inflammation, Injection site swelling
Clinical narrative: Information has been received from a Doctor of Pharmacy concerning a 38 year old female diabetic who on 30-NOV-2006 was vaccinated in the arm with her first dose of Pneumovax 23, lot #655055/0749F.  The patient also received an unspecified influenza virus vaccine in the other arm.  On the same day the patient developed a red area around the injection site approximately 5 inches in diameter.  The pharmacist indicated proper aseptic vaccination technique was employed and would like a lot check performed.  The patient's outcome was unknown.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Follow up information has been received from  Registered Pharmacist concerning the 36 year old patient (originally reported as 38), who on 30-NOV-2006 was vaccinated "SQ" in the left deltoid with her first dose of Pneumovax 23, lot #655054/0749F.  It was reported that: "Aseptic technique was used; IM injection in left deltoid after prepping vial and arm with separate alcohol swabs.  No blood was noted upon needle withdrawal.  Patient noted no initial complaint.  Patient called the following day at approximately 10:00 a.m. noting inflamed left deltoid and a swollen area of approximately 5 inches by 6 inches.  She had called a physician; recommendations of ice/BENADRYL.  I reinforced those recommendations and strongly urged patient to follow up with physician and...pharmacy."  On 02-DEC-2006 the reporter called the patient, she was "fine" and the redness was resolving.  She was reported as recovered from inflamed left deltoid and swollen area.  Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Blood creatine phosphokinase normal, Blood folate normal, C-reactive protein normal, Chills, Erythema
Clinical narrative: Initial and follow up information has been received from a physician and an LPN concerning a 66 year old female patient who on 27-NOV-2006 was vaccinated in the right arm with a dose of Pneumovax 23, lot #651437/0899F.  A dose of Zostavax (MSD), lot #652966/0623F, was administered at the same time in the left arm.  The patient also received a dose of FLUZONE at the same office visit.  On 27-NOV-2006, within 24 hours, the patient developed a fever of 103 degrees.  It was also noted that on 27-NOV-2006 the patient developed redness ("developed over 48 hours"); and severe swelling in the right arm.  The patient said she received Zostavax (MSD) in the right arm, however the physician stated that Pneumovax 23 was given in the right arm and Zostavax (MSD) was given in the left.  The physician reported that her right arm had redness and swelling and spread to arm pit, measuring 8" by 3".  She was treated with BENADRYL and TYLENOL, and DARVOCET was given for pain.  The nurse stated that the patient called the office to say that she had developed shingles in the arm in which she was vaccinated with Pneumovax 23 (Zostavax (MSD) was given in a different arm).  The patient refused to come into the office so that the physician could evaluate or confirm what the patient was saying.  As of 01-DEC-2006, the patient was recovering; all symptoms were much improved.  Additional follow up information has been received concerning the female with a history of fever after flu vaccination approximately 10 years ago who on 27-NOV-2006 was given her first dose of Pneumovax 23, lot #651437/0899F in her right arm; and her first dose of Zostavax (MSD), lot #652966/0623F in her left arm.  Several hours after the injection the patient reported right arm redness and swelling 8" X 3"; and chills and subjective fever on 30-NOV-2006.  An office visit was recommended but the patient declined.  Treatment included ice-packs.  On 19-JAN-2007 the patient received MEDRO DOSEPAK and VICODIN for "resultant myalgia in the arms".  A neurology consult was recommended on 19-JAN-2007 but the patient has not seen a neurologist.  Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Full blood count normal, Herpes zoster, Myalgia, Oedema peripheral, Pyrexia
Clinical narrative: Initial and follow up information has been received from a physician and an LPN concerning a 66 year old female patient who on 27-NOV-2006 was vaccinated in the right arm with a dose of Pneumovax 23, lot #651437/0899F.  A dose of Zostavax (MSD), lot #652966/0623F, was administered at the same time in the left arm.  The patient also received a dose of FLUZONE at the same office visit.  On 27-NOV-2006, within 24 hours, the patient developed a fever of 103 degrees.  It was also noted that on 27-NOV-2006 the patient developed redness ("developed over 48 hours"); and severe swelling in the right arm.  The patient said she received Zostavax (MSD) in the right arm, however the physician stated that Pneumovax 23 was given in the right arm and Zostavax (MSD) was given in the left.  The physician reported that her right arm had redness and swelling and spread to arm pit, measuring 8" by 3".  She was treated with BENADRYL and TYLENOL, and DARVOCET was given for pain.  The nurse stated that the patient called the office to say that she had developed shingles in the arm in which she was vaccinated with Pneumovax 23 (Zostavax (MSD) was given in a different arm).  The patient refused to come into the office so that the physician could evaluate or confirm what the patient was saying.  As of 01-DEC-2006, the patient was recovering; all symptoms were much improved.  Additional follow up information has been received concerning the female with a history of fever after flu vaccination approximately 10 years ago who on 27-NOV-2006 was given her first dose of Pneumovax 23, lot #651437/0899F in her right arm; and her first dose of Zostavax (MSD), lot #652966/0623F in her left arm.  Several hours after the injection the patient reported right arm redness and swelling 8" X 3"; and chills and subjective fever on 30-NOV-2006.  An office visit was recommended but the patient declined.  Treatment included ice-packs.  On 19-JAN-2007 the patient received MEDRO DOSEPAK and VICODIN for "resultant myalgia in the arms".  A neurology consult was recommended on 19-JAN-2007 but the patient has not seen a neurologist.  Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Red blood cell scan, Vitamin B12 normal
Clinical narrative: Initial and follow up information has been received from a physician and an LPN concerning a 66 year old female patient who on 27-NOV-2006 was vaccinated in the right arm with a dose of Pneumovax 23, lot #651437/0899F.  A dose of Zostavax (MSD), lot #652966/0623F, was administered at the same time in the left arm.  The patient also received a dose of FLUZONE at the same office visit.  On 27-NOV-2006, within 24 hours, the patient developed a fever of 103 degrees.  It was also noted that on 27-NOV-2006 the patient developed redness ("developed over 48 hours"); and severe swelling in the right arm.  The patient said she received Zostavax (MSD) in the right arm, however the physician stated that Pneumovax 23 was given in the right arm and Zostavax (MSD) was given in the left.  The physician reported that her right arm had redness and swelling and spread to arm pit, measuring 8" by 3".  She was treated with BENADRYL and TYLENOL, and DARVOCET was given for pain.  The nurse stated that the patient called the office to say that she had developed shingles in the arm in which she was vaccinated with Pneumovax 23 (Zostavax (MSD) was given in a different arm).  The patient refused to come into the office so that the physician could evaluate or confirm what the patient was saying.  As of 01-DEC-2006, the patient was recovering; all symptoms were much improved.  Additional follow up information has been received concerning the female with a history of fever after flu vaccination approximately 10 years ago who on 27-NOV-2006 was given her first dose of Pneumovax 23, lot #651437/0899F in her right arm; and her first dose of Zostavax (MSD), lot #652966/0623F in her left arm.  Several hours after the injection the patient reported right arm redness and swelling 8" X 3"; and chills and subjective fever on 30-NOV-2006.  An office visit was recommended but the patient declined.  Treatment included ice-packs.  On 19-JAN-2007 the patient received MEDRO DOSEPAK and VICODIN for "resultant myalgia in the arms".  A neurology consult was recommended on 19-JAN-2007 but the patient has not seen a neurologist.  Additional information is not expected.
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral, Pain, Tenderness
Clinical narrative: Initial and follow-up information has been received from a physician and a female consumer who in 2005 was vaccinated with Pneumovax 23 (manufacturer unknown).  Subsequently, the patient's arm tripled in size from swelling.  She also experienced soreness and pain.  There was no PQC.  In follow-up it was reported that the patient had swelling, erythema, left (L) arm and tenderness that resolved.  The patient recovered.  No additional information is expected.
Age: 71.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Mobility decreased, Pain, Swelling
Clinical narrative: Information has been received from an office worker concerning a 71 year old female who on 28-NOV-2006 was vaccinated IM with a 0.5 ml dose of Pneumovax 23 (lot #655291/0985F).  There was no concomitant medication.  On 29-NOV-2006 the patient developed swelling, redness, pain and she was unable to lift her arm.  The patient sought medical attention and was treated with unspecified antibiotics.  There were no laboratory or diagnostic tests performed.  At the time of the report, the patient's swelling, redness and pain and inability to lift her arm persisted.  Additional information has been requested.
Age: 69.0
Sex: M
Vaccine: PPV
Symptoms: Neuropathy peripheral, Paraesthesia
Clinical narrative: Information has been received from a 69 year old male physician with hypercholesterolaemia, hypothyroidism, benign prostatic hyperplasia, penicillin and sulfonamide allergy and a history of stent placement 2 years ago who on 15-NOV-2006 was vaccinated IM, into the right arm, with a dose of Pneumovax 23.  Concomitant therapy included LIPITOR, ezetimibe (MSD), SYNTHROID, atenolol (MSD), FLOMAX and AVODART.  On approximately 17-NOV-2006 the patient developed paresthesia and neuropathy in his right arm and right leg.  He reported that the experience is not constant but rather, "it comes and goes."  Unspecified medical attention was sought.  At the time of the report, the paresthesia and neuropathy persisted.  Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: Initial and follow-up information has been received from a physician concerning a 68 year old retired female with a thyroid nodule and raised cholesterol levels and a history of drug reaction to amoxicillin (laryngeal oedema) who on 23-OCT-2006, at 4 p.m., was vaccinated IM, into the left deltoid, with a 0.5 ml first dose of Pneumovax 23 (lot #651401/0619F). Concomitant therapy included Crestor. Several days after the vaccination, the patient experienced pain of the the left upper extremity, 4 to 6 inches above the injection site. There was no redness or swelling. Medical attention was sought and the patient was treated with ibuprofen. There were no laboratory or diagnostic tests performed. At the time of the report, the patient's outcome was unknown. The reporting physician considered the patient's pain in left upper arm to be disabling. No additional is not expected.
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis
Clinical narrative: Information has been received from a 75 year old female with no relevant medical history reported who on 30-NOV-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23 (lot 655291/0985F).  Concomitant therapy included ezetimibe (MSD), simvastatin (MSD), diazepam, aspirin and "enduril".  On 30-NOV-2006, approximately 2 hours post vaccination, the patient developed cellulitis.  The patient sought unspecified medical attention.  At the time of this report, the patient was recovering.  Additional information has been requested.
Age: 82.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site irritation, Injection site pruritus
Clinical narrative: Information has been received from an office manager concerning an 82 year old female who on 17-NOV-2006 was vaccinated with first dose of Pneumovax 23 (lot # 651356/0089F) intramuscularly in left deltoid at 1330 hours.  Concomitant therapy included LIPITOR, aspirin, metformin, LANTUS, ALPLAX and therapy unspecified.  Subsequently, in November 2006, the patient experienced redness, burning, and itching of left upper arm.  The patient sought medical attention.  The patient was treated with BENADRYL and KEFLEX.  The outcome of events was not reported.  No further information is available.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a medical assistant concerning a 68 year old female with diabetes mellitus who on 04-DEC-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23 (Lot 651399/0486F). Concomitant therapy included Metformin. On 04-DEC-2006, the site of injection for the patient was red, swollen, hot to touch, and very hard. The area was sensitive to the touch and the pain made sleeping difficult. The patient also ran a slight temperature. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. The office requested a lot check be performed on lot 651399/0486F. The records of testing prior to release of the lot in question have been rechecked and were found to be satisfactory. The lot complies with the agency and was released. Additional information has been requested.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a nurse practitioner concerning a 65 year old male with no relevant medical history reported who on 04-DEC-2006 was vaccinated with a dose of Pneumovax 23. Concomitant therapy included Avodart and Flomax. The patient developed a red, swollen area at the injection site with fever four hours after receiving the vaccination. On 05-DEC-2006, the patient had 20 centimeter in diameter that was red, swollen, and tender to the touch. The patient sought unspecified medical attention. At the time of this report, the patient's cellulitis persisted. It was unknown if the patient had received a previous Pneumovax 23. The patient's cellulitis was considered to be disabling by the reporter. Additional information has been requested.
Age: 59.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Nausea
Clinical narrative: Information has been received from a medical assistant concerning a 59 year old female with diabetes mellitus who on 04-DEC-2006 was vaccinated with a dose of Pneumovax 23 (lot 651399/0486F).  Concomitant therapy included metformin.  On 04-DEC-2006 the patient developed redness, swelling, heat, and pain at the injection site.  The patient also experienced nausea and pain when moving her arm.  The patient sought unspecified medical attention.  At the time of this report, the outcome was unknown.  The office requested a lot check be performed on lot 651399/0486F.  The records of testing prior to release of the lot in question have been rechecked and were found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Age: 59.0
Sex: F
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: Information has been received from a medical assistant concerning a 59 year old female with diabetes mellitus who on 04-DEC-2006 was vaccinated with a dose of Pneumovax 23 (lot 651399/0486F).  Concomitant therapy included metformin.  On 04-DEC-2006 the patient developed redness, swelling, heat, and pain at the injection site.  The patient also experienced nausea and pain when moving her arm.  The patient sought unspecified medical attention.  At the time of this report, the outcome was unknown.  The office requested a lot check be performed on lot 651399/0486F.  The records of testing prior to release of the lot in question have been rechecked and were found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Local reaction, Pain in extremity
Clinical narrative: Initial and follow-up information has been received from a registered nurse and a certified medical assistant concerning a 70 year old, male patient, whose reported weight was 229 pounds and 74 inches, who on 12-DEC-2006 was vaccinated intramuscularly into the left arm with a second dose of Pneumovax 23 (lot #655587/0882F).  Subsequently the patient developed an arm very painful and red and a local reaction.  Unspecified medical attention was sought.  At the time of the report, the patient had recovered.  It was reported that the patient had "HMG" prior to vaccination.  Additional information has been requested.
Age: 39.0
Sex: F
Vaccine: PPV
Symptoms: Injection site reaction, Skin reaction
Clinical narrative: This report was received form agency and was assigned manufacturer report number SR1-38257463 concerning a 39 year old female who on an unspecified date was vaccinated with Pneumovax 23. Subsequently, the patient developed a skin reaction at injection site. At the time of the event, the patient was also taking REBIF. At the time of this report, the outcome of the event was unknown. This was originally reported by a consumer. No further information is available.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Contusion, Erythema, Musculoskeletal pain, Oedema peripheral, Pain in extremity
Clinical narrative: Information has been received from a 53 year old female registered nurse with unspecified environmental allergies, an adhesive tape allergy and had a history of fibromyalgia and "reflux" who on 01-DEC-2006 was vaccinated with the first dose of Pneumovax 23. Concomitant therapy included SYNTHROID, CLARINEX, TOPAMAX, PROTONIX and an unspecified therapy for allergies. On 01-DEC-2006, "within a few hours", her right arm was very swollen and sore. Later that day, the area was noted to be red and hot, 3 x 4 inches across. The patient notified the doctor and took BENADRYL 50 mg. On 02-DEC-2006, in the morning, the patient was seen in urgent care. The area was noted as "2/3's of upper arm from elbow to shoulder and 2/3's of circumference of arm with pain in shoulder and axilla." The patient was treated with a DECADRON injection and a MEDROL DOSEPAK. The area had improved with slight bruising remaining. At the time of this report, the patient was recovering from the events. Additional information has been requested.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Skin warm
Clinical narrative: Information has been received from a 53 year old female registered nurse with unspecified environmental allergies, an adhesive tape allergy and had a history of fibromyalgia and "reflux" who on 01-DEC-2006 was vaccinated with the first dose of Pneumovax 23. Concomitant therapy included SYNTHROID, CLARINEX, TOPAMAX, PROTONIX and an unspecified therapy for allergies. On 01-DEC-2006, "within a few hours", her right arm was very swollen and sore. Later that day, the area was noted to be red and hot, 3 x 4 inches across. The patient notified the doctor and took BENADRYL 50 mg. On 02-DEC-2006, in the morning, the patient was seen in urgent care. The area was noted as "2/3's of upper arm from elbow to shoulder and 2/3's of circumference of arm with pain in shoulder and axilla." The patient was treated with a DECADRON injection and a MEDROL DOSEPAK. The area had improved with slight bruising remaining. At the time of this report, the patient was recovering from the events. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis
Clinical narrative: Information has been received from a pharmacist concerning a 66 year old female who on 08-DEC-2006 was vaccinated subcutaneously with 0.5 mL of Pneumovax 23.  Subsequently, the patient developed cellulitis which had increased in diameter.  The pharmacist recommended the patient take TYLENOL and BENADRYL.  The physician recommended symptomatic care; cool compresses and anti-inflammatories and reported "immune response should resolve with time".  At the time of this report, the cellulitis was worsening.  Additional information has been requested.  07/30/2008 This is in follow-up to report(s) previously submitted on 7/30/2007. Additional information is not expected.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Injection site bruising, Injection site pain, Skin warm, Tenderness
Clinical narrative: Information has been received from a 65 year old male nurse with hypertension and high cholesterol who on an unspecified date "more than five years ago" in approximately 2001 was vaccinated with a first dose of Pneumovax 23. No adverse symptoms were noted. On 06-DEC-2006, the nurse was vaccinated intramuscularly with a 0.5 mL second dose of Pneumovax 23 (lot 651399/0486F). The patient had a chest cold for the past 3 weeks at the time of vaccination. Concomitant therapy included atenolol, LIPITOR, DYAZIDE, DAYQUIL, and vitamins (unspecified). Later that day on 06-DEC-2006, the patient's arm was bruised and sore at the injection site, and he applied ice. The next morning on 07-DEC-2006, the side of his arm was also affected. The area was 5x3 inches and was red, warm, and tender. He took diphenhydramine HCl for the symptoms. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Additional information received from a physician indicated that the physician did not order the vaccination, and did not observe or advise the patient on his experience. No additional information is expected.
Age: 38.0
Sex: F
Vaccine: PPV
Symptoms: Chest pain, Dizziness, Haematology test, Vision blurred
Clinical narrative: Information has been received from a 38 year old female with diabetes and allergy to Septra who on 22-NOV-2006 was vaccinated with Pneumovax 23 (lot # 655289/0958F) (IM).  Concomitant therapy included ACTOPLUS MET.  On 22-NOV-2006, "within two hours" of getting the shot, she experienced "sharp chest pain," she felt like she "was going to pass out", and she was "unable to focus" her vision.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 0.2
Sex: F
Vaccine: PPV
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 2 month old female who on 13-DEC-2006 was vaccinated with Pneumovax 23 (lot # 655588/0883F), instead of PREVNAR.  The nurse confirmed that this was not product confusion, but a staff error.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Bed rest, Body temperature decreased, Feeling abnormal, Injection site swelling, Oedema peripheral
Clinical narrative: Information has been received from a registered nurse concerning a 68 year old male with allergy to penicillin and shellfish who in 1997 was vaccinated with first dose of Pneumovax 23 and on 15-NOV-2006 was vaccinated with greater than third dose of Fluvirin (Chiron) (lot # 72008) IM in the right deltoid at 4:40 PM.  The patient had no acute illness at the time of being vaccinated.  On 01-DEC-2006, the patient was vaccinated with a second dose of 0.5 mL dose of Pneumovax 23 (lot # 651437/0899F) IM in the right deltoid at 10:40 AM.  Subsequently, the same day, the patient developed "unusually high swelling of the arm at the shot sight."  Two days later, the patient was recovered.  Additional information was received from the registered nurse.  The patient's wife called the office and reported that on 01-DEC-2006, in the evening, her husband experienced swelling and tenderness in his right arm, temperature was below normal.  The patient "felt very bad" and stayed in bed most of the day on 02-DEC-2006.  The patient did not remember the exact date of recovery but had recovered by 05-DEC-2006.  No additional information is expected.
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Tenderness
Clinical narrative: Information has been received from a registered nurse concerning a 68 year old male with allergy to penicillin and shellfish who in 1997 was vaccinated with first dose of Pneumovax 23 and on 15-NOV-2006 was vaccinated with greater than third dose of Fluvirin (Chiron) (lot # 72008) IM in the right deltoid at 4:40 PM.  The patient had no acute illness at the time of being vaccinated.  On 01-DEC-2006, the patient was vaccinated with a second dose of 0.5 mL dose of Pneumovax 23 (lot # 651437/0899F) IM in the right deltoid at 10:40 AM.  Subsequently, the same day, the patient developed "unusually high swelling of the arm at the shot sight."  Two days later, the patient was recovered.  Additional information was received from the registered nurse.  The patient's wife called the office and reported that on 01-DEC-2006, in the evening, her husband experienced swelling and tenderness in his right arm, temperature was below normal.  The patient "felt very bad" and stayed in bed most of the day on 02-DEC-2006.  The patient did not remember the exact date of recovery but had recovered by 05-DEC-2006.  No additional information is expected.
Sex: U
Vaccine: PPV
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a pharmacist who reported that a patient had an unspecified reaction to Pneumovax 23 (Lot # 655053/0743F).  The pharmacist did not have any specifics.  The patient sought unspecified medical attention.  At the time of the report, it was not reported if the patient recovered.  Additional information has been requested.
Age: 0.25
Sex: U
Vaccine: PNC, PPV
Symptoms: Wrong drug administered
Clinical narrative: Initial and follow-up information has been received from a pharmacist concerning a 3 month old patient who was vaccinated with a dose of Pneumovax 23 instead of Prevnar. The pharmacist reported that the event was a mistake in dispensing by the pharmacy. A new pharmacist filled the order for Pneumovax 23 instead of Prevnar unaware of the difference in the products. The nurse on the floor did not check the order carefully, just seeing "pneumococcal vaccine." The pharmacist stated that in response to the event, the vaccines are now stored at opposite ends of the pharmacy and that the new pharmacist and nurse were provided with more education on the products. The patient sought unspecified medical attention. There were no problems were noted. Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Urticaria
Clinical narrative: Information has been received from a nurse in a hospital via a registered pharmacist concerning a 63 year old male with codeine allergy who was vaccinated with Pneumovax 23.  Subsequently the patient experienced hives.  The nurse wanted to know if she should vaccinate the patient with influenza vaccine if the patient had hives in the past after received Pneumovax 23.  Unspecified medical attention was sought.  No further information is available.
Age: 62.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Body temperature, Injection site erythema, Injection site swelling, No reaction on previous exposure to drug
Clinical narrative: Initial and follow-up information has been received from a licensed practical nurse concerning a 62 year old male with no allergies who on 15-NOV-2006 was vaccinated IM in the deltoid with a second dose, 0.5 mL, of Pneumovax 23 (lot # 654982/0675F).  On 15-NOV-2006, the patient's arm swelled from the injection site in his deltoid to his elbow.  Follow up information from the nurse indicated that on 16-NOV-2006, the patient developed redness and swelling at the injection site.  The patient had no fever or respiratory symptoms.  The patient did not have any intervention for the reaction and has recovered.  The nurse reported that the patient recovered (date not reported).  It was also noted that the patient had his first injection with Pneumovax 23 five years ago and had no reaction.  A product quality complaint was not involved.  Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site swelling, No reaction on previous exposure to drug
Clinical narrative: Initial and follow-up information has been received from a licensed practical nurse concerning a 62 year old male with no allergies who on 15-NOV-2006 was vaccinated IM in the deltoid with a second dose, 0.5 mL, of Pneumovax 23 (lot # 654982/0675F).  On 15-NOV-2006, the patient's arm swelled from the injection site in his deltoid to his elbow.  Follow up information from the nurse indicated that on 16-NOV-2006, the patient developed redness and swelling at the injection site.  The patient had no fever or respiratory symptoms.  The patient did not have any intervention for the reaction and has recovered.  The nurse reported that the patient recovered (date not reported).  It was also noted that the patient had his first injection with Pneumovax 23 five years ago and had no reaction.  A product quality complaint was not involved.  Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Body temperature, Injection site erythema, Injection site swelling, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a licensed practical nurse concerning a 62 year old male with no known allergies reported who in 2001 was vaccinated with Pneumovax 23 and had no reaction.  On 15-NOV-2006, the patient was vaccinated intramuscularly in the deltoid with the second dose of Pneumovax 23 (Lot# 654982/0675F).  On 15-NOV-2006, "shortly after the injection was given", the patient complained his arm swelled from the injection site in his deltoid to his elbow.  The patient had no fever or respiratory symptoms. The patient had no intervention for the reaction and had recovered (date unknown).  The nurse reported that she did not know how long the reaction had lasted.  Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site swelling, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a licensed practical nurse concerning a 62 year old male with no known allergies reported who in 2001 was vaccinated with Pneumovax 23 and had no reaction.  On 15-NOV-2006, the patient was vaccinated intramuscularly in the deltoid with the second dose of Pneumovax 23 (Lot# 654982/0675F).  On 15-NOV-2006, "shortly after the injection was given", the patient complained his arm swelled from the injection site in his deltoid to his elbow.  The patient had no fever or respiratory symptoms. The patient had no intervention for the reaction and had recovered (date unknown).  The nurse reported that she did not know how long the reaction had lasted.  Additional information has been requested.
Sex: F
Vaccine: PPV
Symptoms: Malaise
Clinical narrative: Information has been received from a pharmacist concerning a female patient who "not recently" was vaccinated with a first dose of Pneumovax 23.  Subsequently the patient "got a little sick".  Unspecified medical attention was sought.  It was reported that the patient recently received another dose of Pneumovax 23, and had no problems.  No further information is available.
Age: 49.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: Information has been received from a physician and an other health professional concerning a 49 year old female with chronic obstructive pulmonary disease, hypothyroid, migraines and depression and allergies to codeine, STADOL, morphine, sulfa and LORTAB who on 08-DEC-2006 at 8:30 was vaccinated intramuscularly in the right deltoid with a 0.5 mL second dose of Pneumovax 23 (Lot # 651401/0619F).  On the evening of 08-DEC-2006, the patient experienced pain in the right deltoid, shoulder and upper arm after receiving Pneumovax 23.  The patient sought unspecified medical attention.  The patient was treated prophylactically with KEFLEX 250 mg and DARVOCET for pain.  On 01-JAN-2007, the patient's arm was checked and no symptoms were noted or reported.  No product quality complaint was involved.  Additional information is not expected.
Sex: M
Vaccine: PPV
Symptoms: Accidental exposure, Vision blurred
Clinical narrative: Information has been received from a pharmacist who is also a clinician who in 2005 was vaccinated with a dose of Pneumovax 23.  In 2005 the patient developed swelling at the injection site (outcome not reported).  On 15-DEC-2006 while administering a dose of Pneumovax 23 (lot #651330/1048P) the plunger separated from the needle and the vaccine splashed in his face and right eye.  Subsequently his right eye became blurry.  Unspecified medical attention was sought.  He washed his right eye with water.  At the time of the report, the patient's blurred vision persisted.  Additional information is not expected.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a pharmacist via a nurse on a hospital floor who wished to give a 63 year old male inpatient (with an allergy to codeine) a dose of influenza vaccine, but was unsure if she should since he developed hives in the past after receiving Pneumovax 23.  It was unknown if influenza vaccine was given.  The patient's outcome was not reported.  No further information is available.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (3 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site which was 3 inches in diameter and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site which was 3 inches in diameter and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (4 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (5 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (6 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (7 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (9 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (10 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (11 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (12 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (13 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (14 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (15 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (16 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (17 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (18 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.